Posted in | News

Innovative Composites Receives More Purchase Orders for Engineered Enclosures

Innovative Composites International Inc. ("ICI" or the "Company"), (TSXV: IC) (OTCQX: ICIZF, a producer of proprietary engineered composite products, announced today that it has delivered the specifically engineered enclosures from the previously announced first production order and that it has received purchase orders for additional enclosures, which bring the total number of enclosures ordered to 16.

The enclosures are all approximately 8' wide and 8' tall and range in size from 28' to 54' long. The Company is producing these enclosures in its Orangeburg, South Carolina facility and these orders represent the first recurring revenue generated by that facility. The customer, who is a global leader in the heating, air conditioning, and refrigeration market, has continued to request that their name not be released for competitive reasons. The Company is working on several different new enclosure designs for possible adoption by this customer.

"These enclosures were custom-engineered for this customer based on their specifications and are a result of a tremendous amount of work and a cooperative effort by teams on both sides," said Terry Ball, President and CEO of ICI. "They were made possible because of the attributes of ICI's proprietary thermoplastic RMor SkinTM, such as its significant weight-to-strength ratio, resistance to the elements, and because of its versatility and flexibility. We are very pleased with the performance of the production equipment in our South Carolina facility and we are proud to have been chosen as a supplier for these enclosures. We are working diligently with this world-class customer to expand this relationship going forward."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.